198 related articles for article (PubMed ID: 34618172)
1. Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.
Sun J; Wang Z; Sheng Y; Ming X; Jiang GL; Wang W
Strahlenther Onkol; 2022 Apr; 198(4):361-369. PubMed ID: 34618172
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
Ma N; Ming X; Chen J; Wu KL; Lu J; Jiang G; Mao J
Radiat Oncol; 2023 Dec; 18(1):195. PubMed ID: 38041122
[TBL] [Abstract][Full Text] [Related]
3. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
[TBL] [Abstract][Full Text] [Related]
4. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world.
Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ
Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
6. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
[TBL] [Abstract][Full Text] [Related]
7. A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.
Chen D; Wang R; Meng X; Liu T; Yan H; Feng R; Liu S; Jiang S; Xu X; Zhu K; Dou X
Radiat Oncol; 2014 Feb; 9():48. PubMed ID: 24502643
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
12. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
13. Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study.
Qiu X; Gao J; Yang J; Hu J; Hu W; Huang Q; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1193. PubMed ID: 36544659
[TBL] [Abstract][Full Text] [Related]
14. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
[TBL] [Abstract][Full Text] [Related]
15. Development of a Vaginal Immobilization Device: A Treatment-planning Study of Carbon-ion Radiotherapy and Intensity-modulated Radiation Therapy for Uterine Cervical Cancer.
Kubota Y; Ohno T; Kawashima M; Murata K; Okonogi N; Noda SE; Tsuda K; Sakai M; Tashiro M; Nakano T
Anticancer Res; 2019 Apr; 39(4):1915-1921. PubMed ID: 30952733
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
[TBL] [Abstract][Full Text] [Related]
17. Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300).
Gugliandolo SG; Marvaso G; Comi S; Pepa M; Romanò C; Zerini D; Augugliaro M; Russo S; Vischioni B; Valvo F; Giandini T; Avuzzi B; Valdagni R; Ciardo D; De Cobelli O; Jereczek-Fossa BA; Cattani F; Orecchia R
Phys Med; 2020 Aug; 76():327-336. PubMed ID: 32750548
[TBL] [Abstract][Full Text] [Related]
18. In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.
Yamada M; Sato H; Ieko Y; Miyasaka Y; Kanai T; Yano N; Ono T; Akamatsu H; Harada M; Ichikawa M; Teranishi Y; Kikuchi Y; Nemoto K
Radiat Oncol; 2019 Nov; 14(1):207. PubMed ID: 31752932
[TBL] [Abstract][Full Text] [Related]
19. RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.
Park JM; Kim K; Chie EK; Choi CH; Ye SJ; Ha SW
Br J Radiol; 2012 Jul; 85(1015):e323-9. PubMed ID: 22745211
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
